Hashida et al., "Hepatic targeting of drugs and proteins by chemical modification," Journal of Controlled Release 36(1): 99-107, 1995. |
Kasina et al., "Preformed Chelate TC-99m Radiolabeling Of r-Annexin V For Arterial Thrombus Imaging," Journal of Nuclear Medicine 37(Suppl. 5): 29P., 1996. |
Prescott et al., "Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa arabinogalactan fragment," Carbohydrate Research 278(1): 113-128, 1995. |
Alderson, "Scintigraphic Diagnosis of Pulmonary Embolism: Where Do We Go From Here?" Radiology, vol. 193, pp. 22-23, 1994. |
Baldwin et al., "Purification and Partial Amino Acid Sequence of Annexin V from Porcine Gastric Mucosal Membranes," Comp. Biochem. Physiol., vol. 100B, No. 4, pp. 661-665, 1991. |
Bautovich et al., "Detection of Deep Venous Thrombi and Pulmonary Embolus with Technetium-99m-DD-3B6/22 Anti-fibrin Monoclonal Antibody Fab' Fragment," The Journal of Nuclear Medicine, vol. 35, No. 2, pp. 195-202, 1994. |
Biessen et al., "Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor," J. Med. Chem., vol. 38, pp. 1538-1546, 1995. |
Bryson et al., "Protecting Groups in the Preparation of Thiolate Complexes of Technetium," Inorganic Chemistry, vol. 29, No. 16, pp. 2948-2951, 1990. |
Cerqueira et al., "Noninvasive Arterial Thrombus Imaging with .sup.99m Tc Monoclonal Antifibrin Antibody," Circulation, vol. 85, No. 1, pp. 293-304, 1992. |
Crumpton, "Protein Terminology Tangle," Nature, vol. 345, p. 212, 1990. |
De Bruyn et al., "Visualization of Thrombi in Pulmonary Arteries with Radiolabeled, Enzymatically Inactivated Tissue-Type Plasminogen Activator," 1995 , vol. 92, No. 5, pp. 1320-1325. |
Demange et al., "Annexin V: The Key to Understanding Ion Selectivity and Voltage Regulation?," TIBS, vol. 19, pp. 272-276, 1994. |
Fernandez et al., "The Structure of Anchorin CII, a Collagen Binding Protein Isolated from Chondrocyte Membrane," J. Biolog. Chem., vol. 236, No. 12, pp. 5921-5925, 1988. |
Findeis, "Stepwise Synthesis of a GalNAc-containing Cluster Glycoside Ligand of the Asialoglycoprotein Receptor," Int. J. Peptide Protein Res., vol. 43, pp. 477-485, 1994. |
Flaherty et al., "Placental Anticoagulant Protein-I: Measurement in Extracellular Fluids and Cells of the Hemostatic System," The Journal of Laboratory and Clinical Medicine, vol. 115, No. 2, pp. 174-181, 1990. |
Fraker et al., "Protein and Cell Membrane Iodinations with a Sparingly Soluble Chloroamide, 1,3,4,6-tetrachloro-3a, 6a-diphenylglycoluril," Biochemical and Biophysical Research Communications, vol. 80, No. 4, pp. 849-857, 1978. |
Fritzberg et al., "Specific and Stable Labeling of Antibodies with Technetium-99m with a Diamide Dithiolate Chelating Agent," Proc. Natl. Acad. Sci. USA, vol. 85, pp. 4025-4029, 1988. |
Funakoshi et al., "Human Placental Anticoagulant Protein: Isolation and Characterization," Biochemistry, vol. 26, pp.5572-5578, 1987. |
Funakoshi et al., "Primary Structure of Human Placental Anticoagulant Protein," Biochem., vol. 26, pp. 8087-8092, 1987. |
Galli et al., "A Radiopharmaceutical for the Study of the Liver: .sup.99m Tc-DTPA-Asialo-Orosomucoid, I: Radiochemical and Animal Distribution Studies," J. Nucl. Med. Allied Sci., vol. 32, No. 2, pp. 110-116, 1988. |
Grundmann et al., "Characterization of cDNA Encoding Human Placental Anticoagulant Protein (PP4): Homology with the Lipocortin Family," Proc. Natl. Acad. Sci.. vol. 85, pp. 3708-3712, 1988. |
Habeeb, "Determination of Free Amino Groups In Proteins by Trinitrobenzenesulfonic Acid," Analytical Biochemistry, vol. 14, pp. 328-336, 1966. |
Haensler et al., "Synthesis and Characterization of a Trigalactosylated Bisacridine Compound to Target DNA to Hepatocytes," Bioconjugate Chem., vol. 4, pp. 85-93, 1993. |
Iwasaki et al., "Structure and Expression of cDNA for an Inhibitor of Blood Coagulation Isolated from Human Placenta: A New Lipocortin-like Protein," J. Biochem., vol. 102, pp. 1261-1273, 1987. |
Jansen et al., "Hepatic Endocytosis of Various Types of Mannose-terminated Albumins," J. of Biological Chem., vol. 266, No. 5, pp. 3343-3348, 1991. |
Kaplan et al., "Cloning and Expression of cDNA for Human Endonexin II, a Ca.sup.2+ and Phospholipid Binding Protein," J. Biolog. Chem., vol. 263, No. 17, pp. 8037-8043, 1988. |
Kasina et al., "Development and Biologic Evaluation of a Kit for Preformed Chelate Technetium-99m Radiolabeling of an Antibody Fab Fragment Using a Diamide Dimercaptide Chelating Agent," The Journal of Nuclear Medicine, vol. 32, No. 7, pp. 1445-1451, 1991. |
Knight et al., "Thrombus Imaging with Technetium-99m Synthetic Peptides Based upon the Binding Domain of a Monoclonal Antibody to Activated Platelets," The Journal of Nuclear Medicine, vol. 35, No. 2, pp. 282-288, 1994. |
Koblick et al., "Current Status of Immunoscintigraphy in the Detection of Thrombosis and Thromboembolism," Seminars in Nuclear Medicine, vol. XIX, No. 3, pp. 221-237, 1989. |
Krantz et al., "Attachment of Thioglycosides to Proteins: Enhancement of Liver Membrane Binding," Biochem., vol. 15, No. 18, pp. 3963-3968, 1976. |
Law, et al., "A Microplate Method for the Determination of Amino Groups in Monoclonal Antibodies," Hybridoma, vol. 9, No. 4, pp. 397-399, 1990. |
Lee et al., "New Synthetic Cluster Ligands for Galactose/N-Acetylgalactosamine-specific Lectin of Mammalian Liver," Biochem., vol. 23, pp. 4255-4261, 1984. |
Lee et al., "Preparation of Cluster Glycosides of N-Acetylgalactosamine That Have Subnanomolar Binding Constants Towards the Mammalian Hepatic Gal/GalNAc-specific Receptor," Glycoconjugate J., vol. 4, pp. 317-328, 1987. |
Lee et al., "2-Imino-2-methoxyethyl 1-thioglycosides: New Reagents for Attaching Sugars to Proteins," Biochem., vol. 15, No. 18, pp. 3956-3962, 1976. |
Loscalzo et al., "Imaging Arterial Thrombi: An Elusive Goal," Circulation, vol. 85, No. 1, pp. 385-385, 1992. |
Mattes, "Biodistribution of Antibodies After Intraperitoneal or Intravenous Injection and Effect of Carbohydrate Modifications," J. Natl. Canc. Instit., vol. 79, No. 4, pp. 855-863, 1987. |
Mauk et al., "Targeting of Lipid Vesicles: Specificity of Carbohydrate Receptor Analogues for Leukocytes in Mice," Proc. Natl. Acad. Sci. USA, vol. 77, No. 8, pp. 4430-4434, 1980. |
Maurer-Fogy et al., "Cloning and Expression of cDNA for Human Vascular Anticoagulant, a Ca.sup.2+ -dependent Phospholipid-binding Protein," Eur. J. Biochem., vol. 174, pp. 585-592, 1988. |
Mckee et al., "Preparation of Asialoorosomucoid-polylysine Conjugates," Bioconjugate Chem., vol. 5, pp. 306-311, 1994. |
Merwin et al., "Targeted Delivery of DNA Using YEE(GalNacAH).sub.3, a Synthetic Glycopeptide Ligand for the Asialoglycoprotein Receptor," Bioconjugate Chem., vol. 5, pp. 612-620, 1994. |
Morell et al., "The Role of Sialic Acid in Determining the Survival of Glycoproteins in the Circulation," J. Biol. Chem., vol. 246, No. 5, pp. 1461-1467, 1971. |
Muto et al., "Detecting Deep Venous Thrombosis with Technetium-99m-Labeled Synthetic Peptide P280," The Journal of Nuclear Medicine, vol. 36, pp. 1384-1391, 1995. |
Pepinsky et al., "Five Distinct Calcium and Phospholipid Binding Proteins Share Homology with Lipocortin I," J. Biolog. Chem., vol. 263, No. 22, pp. 10799-10811, 1988. |
Ponpipom et al., "Cell-specific Ligands for Selective Drug Delivery to Tissues and Organs," J. Med. Chem., vol. 24, 1388-1395, 1981. |
Ponpipom et al., "Cell Surface Carbohydrates for Targeting Studies," Can. J. Chem., vol. 58, p. 214, 1980. |
Press Release from American Biogenetic Sciences, "American Biogenetic Sciences, Inc Announces Its Completion of Phase I and Initiation of a Phase I/II Clinical Trial of MH1 for Imaging Blood Clots," 1995. |
Ravant et al., "Use of Annexin-V to Demonstrate the Role of Phosphatidylserine Exposure in the Maintenance of Haemostatic Balance by Endothelial Cells," Biochem. J., vol. 282, pp. 7-13, 1992. |
Romisch et al., "Annexins: Calcium-Binding Proteins of Multi-Functional Importance?," Medical Microbiology and Immunology, vol. 180, pp. 109-126, 1991. |
Romisch et al., "Annexin Proteins PP4 and PP4-X: Comparative Characterization of Biological Activities of Placental and Recombinant Proteins," Biochem. J., vol. 272, pp. 223-229, 1990. |
Romisch et al., "Anticoagulant Properties of Placenta Protein 4 (Annexin V)," Thrombosis Research, vol. 60, No. 5, pp. 355-366, 1990. |
Romisch et al., "In-Vivo Antithrombotic Potency of Placenta Protein 4 (Annexin V)," Thrombosis Research, vol. 61, No.2, pp. 93-104, 1991. |
Sharma et al., "Inactivation and Clearance of an Anti-CEA Carboxypeptidase G2 Conjugate in Blood After Localisation in a Xenograft Model," Br. J. Cancer, vol. 61, pp. 659-662, 1990. |
Sharon et al., "Carbohydrates in Cell Recognition," Scientific American, vol. 268, No. 1, pp. 82-89, 1993. |
Stratton, "Common Causes of Cardia Emboli--Left Ventricular Thrombi and Atrial Fibrilation," The Western Journal of Medicine, vol. 151, No. 2, pp. 172-179, 1989. |
Stratton et al., "The Effects of Antithrombotic Drugs in Patients with Left Ventricular Thrombi: Assessment with Indium-111 Platelet Imaging and Two-Dimensional Echocardiography," Circulation, vol. 69, No. 3, pp. 561-568, 1984. |
Stratton et al., ".sup.111 In Platelet Imaging of Left Ventricular Thrombi," Circulation, vol. 81, No. 4, pp. 1182-1189, 1990. |
Stratton et al., "Indium 111-Labeled Platelet Imaging in Man," New Concepts Cardiac Imag, vol. 3, pp. 139-196, 1987. |
Stratton et al,. "Left Ventricular Thrombi: In Vivo Detection by Indium-111 Platelet Imaging and Two Dimensional Echocardiography," The American Journal of Cardiology, vol. 47, pp. 874-881, 1981. |
Stratton et al., "Platelet Deposition at Carotid Endarterectomy Sites in Humans," Stroke, vol. 18, No. 4, pp. 722-727, 1987. |
Stratton et al., "Reduction of Indium-111 Platelet Deposition on Dacron Vascular Grafts in Humans by Aspirin Plus Dipyridamole," Circulation, vol. 73, No. 2, pp. 325-330, 1986. |
Stratton et al., "Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial Thrombi.," vol. 92, No. 10, pp. 3113-3121, 1995. |
Tait et al., "Chromosomal Localization of the Human Gene for Annexin V (Placental Anticoagulant Protein I) to 4q26.fwdarw.q28," Cytogenet. Cell Genet., vol. 57, pp. 187-192, 1991. |
Tait et al., "Evaluation of Annexin V as a Platelet-Directed Thrombus Targeting Agent," Thrombosis Research, vol. 75, No. 5, pp. 491-501, 1994. |
Tait et al., "Phospholipid Binding of Annexin V: Effects of Calcium and Membrane Phosphatidylserine Content," Archives of Biochemistry and Biophysics, vol. 298, No. 1, pp. 187-191, 1992. |
Tait et al., "Phospholipid Binding Properties of Human Placental Anticoagulant Protein-I, a Member of the Lipocortin Family," J. Biolog. Chem., vol. 264, No. 14, pp. 7944-7949, 1989. |
Tait et al., "Placental Anticoagulant Proteins: Isolation and Comparative Characterization of Four Members of the Lipocortin Family," Biochem., vol. 27, No. 17, pp. 6268-6276, 1988. |
Tait et al., "Site-Specific Mutagenesis of Annexin V: Role of Residues from Arg-200 to Lys-207 in Phospholipid Binding," Archives of Biochemistry and Biophysics, vol. 288, No. 1, pp. 141-144, 1991. |
Tait et al., "Prourokinase-Annexin V Chimeras: Construction, Expression, and Characterization of Recombinant Proteins," The Journal of Biological Chemistry, vol. 270, No. 37, pp. 21594-21599, 1995. |
Taliaferro et al., "New Multidentate Ligands: 22. N,N'-Dipyridoxylethylenediamine-N,N'-diacetic Acid: A New Chelating Ligand for Trivalent Metal Ions," Inorganic Chemistry, vol. 23, No. 8, pp. 1188-1192, 1984. |
Tanaka et al., "Preparation and Characterization of a Disulfide-linked Bioconjugate of Annexin V with the B-chain of Urokinase: An Improved Fibrinolytic Agent Targeted to Phospholipid-containing Thrombi," Biochem., vol. 35, No. 3, pp. 922-929, 1996. |
Thiagarajan et al., "Binding of Annexin V/Placental Anticoagulant Protein I to Platelets: Evidence for Phosphatidylserine Exposure in the Procoagulant Response of Activated Platelets," The Journal of Biological Chemistry, vol. 265, No. 29, pp. 17420-17423, 1990. |
Tolleshaug, "Binding and Internalization of Asialo-glycoproteins by Isolated Rat Hepatocytes," Int. J. Biochem., vol. 13, pp. 45-51, 1981. |
Van Der Sluijs et al., "Drug Targeting to the Liver with Lactosylated Albumins: Does the Glycoprotein Target the Drug or is the Drug Targeting the Glycoprotein?", Hepatology, vol. 6, No. 4, pp. 723-728, 1986. |
Van Heerde et al., "Binding of Recombinant Annexin V to Endothelial Cells: Effect of Annexin V Binding on Endothelial-Cell-Mediated Thrombin Formation," Biochem. J., vol. 302, pp. 305-312, 1994. |
Van Ryn-McKenna et al., "The Effects of Heparin and Annexin V on Fibrin Accretion after Injury in the Jugular Veins of Rabbits," Thrombosis and Haemostasis, vol. 69, No. 3, pp. 227-230, 1993. |
Vera et al., "Tc-99m Galactosyl-Neoglycoalbumin: In Vitro Characterization of Receptor-Mediated Binding," J. Nucl. Med. vol. 5, No. 7, pp. 779-787, 1984. |
Verstraete, "The Diagnosis and Treatment of Deep-vein Thrombosis," The New England Journal of Medicine, vol. 329, No. 19, pp. 1418-1419, 1993. |
Wall et al., "The Galactose-specific Recognition System of Mammalian Liver: the Route of Ligand Internalization in Rat Hepatocytes" Cell, vol. 21, pp. 79-93, 1980. |
Weber et al., "Enhanced Kidney Clearance with an Ester-linked .sup.99m Tc-Radiolabeled Antibody Fab'-chelator Conjugate," Bioconjugate Chem., vol. 1, pp. 431-437, 1990. |
Weigel, "Chapter 14, Mechanisms and Control of Glycoconjugate Turnover," Glycoconjugates Composition, Structure and Function, edited by Allen et al., Marcel Dekker, Inc., New York, pp. 421-497, 1992. |
Weigel, "Chapter 5, Endocytosis and Function of the Hepatic Asialoglycoprotein Receptor," Subcellular Biochemistry, vol. 19, Endocytic Components: Identification and Characterization, edited by Bergeron et al., Plenum Press, New York, pp. 125-161, 1993. |
Weinmann et al., "Deep-vein Thrombosis," The New England Journal of Medicine, vol. 331, No. 24, pp. 1630-1641, 1994. |
Wells et al., "Accuracy of Clinical Assessment of Deep-vein Thrombosis," The Lancet, vol. 345, pp. 1326-1330, 1995. |
Worsley et al., "Role of Radionuclide Imaging in Patients with Suspected Pulmonary Embolism," Nuclear Medicine, vol. 31, No. 4, pp. 849-858, 1993. |